109 related articles for article (PubMed ID: 27412917)
1. ID4 controls luminal lineage commitment in normal mammary epithelium and inhibits BRCA1 function in basal-like breast cancer.
Baker LA; Holliday H; Swarbrick A
Endocr Relat Cancer; 2016 Sep; 23(9):R381-92. PubMed ID: 27412917
[TBL] [Abstract][Full Text] [Related]
2. Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer.
Baker LA; Holliday H; Roden D; Krisp C; Wu SZ; Junankar S; Serandour AA; Mohammed H; Nair R; Sankaranarayanan G; Law AMK; McFarland A; Simpson PT; Lakhani S; Dodson E; Selinger C; Anderson L; Samimi G; Hacker NF; Lim E; Ormandy CJ; Naylor MJ; Simpson K; Nikolic I; O'Toole S; Kaplan W; Cowley MJ; Carroll JS; Molloy M; Swarbrick A
Breast Cancer Res; 2020 Jun; 22(1):63. PubMed ID: 32527287
[TBL] [Abstract][Full Text] [Related]
3. ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype.
Junankar S; Baker LA; Roden DL; Nair R; Elsworth B; Gallego-Ortega D; Lacaze P; Cazet A; Nikolic I; Teo WS; Yang J; McFarland A; Harvey K; Naylor MJ; Lakhani SR; Simpson PT; Raghavendra A; Saunus J; Madore J; Kaplan W; Ormandy C; Millar EK; O'Toole S; Yun K; Swarbrick A
Nat Commun; 2015 Mar; 6():6548. PubMed ID: 25813983
[TBL] [Abstract][Full Text] [Related]
4. Tumoral expression of BRCA1, estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer.
Roldán G; Delgado L; Musé IM
Cancer Biol Ther; 2006 May; 5(5):505-10. PubMed ID: 16582598
[TBL] [Abstract][Full Text] [Related]
5. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
6. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
Thike AA; Tan PH; Ikeda M; Iqbal J
Histopathology; 2016 Apr; 68(5):702-12. PubMed ID: 26259780
[TBL] [Abstract][Full Text] [Related]
7. miR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer.
Crippa E; Lusa L; De Cecco L; Marchesi E; Calin GA; Radice P; Manoukian S; Peissel B; Daidone MG; Gariboldi M; Pierotti MA
PLoS One; 2014; 9(1):e87039. PubMed ID: 24475217
[TBL] [Abstract][Full Text] [Related]
8. Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation.
Wen YH; Ho A; Patil S; Akram M; Catalano J; Eaton A; Norton L; Benezra R; Brogi E
Breast Cancer Res Treat; 2012 Aug; 135(1):93-102. PubMed ID: 22538771
[TBL] [Abstract][Full Text] [Related]
9. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
[TBL] [Abstract][Full Text] [Related]
10. PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors.
Bai F; Liu S; Liu X; Hollern DP; Scott A; Wang C; Zhang L; Fan C; Fu L; Perou CM; Zhu WG; Pei XH
Breast Cancer Res; 2021 Jan; 23(1):10. PubMed ID: 33478572
[TBL] [Abstract][Full Text] [Related]
11. Contemplating chemosensitivity of basal-like breast cancer based on BRCA1 dysfunction.
Ohta T; Wu W; Koike A; Asakawa H; Koizumi H; Fukuda M
Breast Cancer; 2009; 16(4):268-74. PubMed ID: 19459031
[TBL] [Abstract][Full Text] [Related]
12. CDC42 as an epigenetic regulator of ID4 in triple-negative breast tumors.
Nasif D; Real S; Roqué M; Branham MT
Breast Cancer; 2022 May; 29(3):562-573. PubMed ID: 35094293
[TBL] [Abstract][Full Text] [Related]
13. Dual roles for Id4 in the regulation of estrogen signaling in the mammary gland and ovary.
Best SA; Hutt KJ; Fu NY; Vaillant F; Liew SH; Hartley L; Scott CL; Lindeman GJ; Visvader JE
Development; 2014 Aug; 141(16):3159-64. PubMed ID: 25038044
[TBL] [Abstract][Full Text] [Related]
14. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
[TBL] [Abstract][Full Text] [Related]
15. ID4 regulates mammary gland development by suppressing p38MAPK activity.
Dong J; Huang S; Caikovski M; Ji S; McGrath A; Custorio MG; Creighton CJ; Maliakkal P; Bogoslovskaia E; Du Z; Zhang X; Lewis MT; Sablitzky F; Brisken C; Li Y
Development; 2011 Dec; 138(23):5247-56. PubMed ID: 22069192
[TBL] [Abstract][Full Text] [Related]
16. BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.
Buckley NE; Mullan PB
Stem Cell Rev Rep; 2012 Sep; 8(3):982-93. PubMed ID: 22426855
[TBL] [Abstract][Full Text] [Related]
17. The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1.
Pruszko M; Milano E; Forcato M; Donzelli S; Ganci F; Di Agostino S; De Panfilis S; Fazi F; Bates DO; Bicciato S; Zylicz M; Zylicz A; Blandino G; Fontemaggi G
EMBO Rep; 2017 Aug; 18(8):1331-1351. PubMed ID: 28652379
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?
Wang L; Di LJ
Int J Biol Sci; 2014; 10(5):566-75. PubMed ID: 24910535
[TBL] [Abstract][Full Text] [Related]
19. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.
Johnson J; Choi M; Dadmanesh F; Han B; Qu Y; Yu-Rice Y; Zhang X; Bagaria S; Taylor C; Giuliano AE; Amersi F; Cui X
Oncotarget; 2016 Nov; 7(46):75729-75738. PubMed ID: 27708239
[TBL] [Abstract][Full Text] [Related]
20. BRCA1-associated R-loop affects transcription and differentiation in breast luminal epithelial cells.
Chiang HC; Zhang X; Li J; Zhao X; Chen J; Wang HT; Jatoi I; Brenner A; Hu Y; Li R
Nucleic Acids Res; 2019 Jun; 47(10):5086-5099. PubMed ID: 30982901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
